CClinicalTrials.gg
CompletedNCT00877175Updated Mar 9, 2012

Comparison of Instillation and Packing in Mydriasis for Premature Infants

A Phase 4 interventional study of 1% tropicamide and 2.5% phenylephrine in Preterm Infants, sponsored by Khon Kaen University. Completed at 1 site in Thailand. Open to participants aged 1 Month to 4 Months. Per ClinicalTrials.gov, last updated 2012-03-09.

Sponsored by Khon Kaen University · Phase 4, Interventional, and Diagnostic

Phase
Phase 4
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
1 Month to 4 Months
Sex
All
01

Study summary

The purpose of this study is to compare the mydriatic effect of 2.5% phenylephrine and 1% tropicamide by conventional instillation and lower conjunctival fornix packing in premature infants.

Read the detailed description

Adequate pupil dilatation was needed for screening and treatment of retinopathy of prematurity (ROP) in premature infants.In general clinical practice, mydriatic drugs were instilled many times until the pupil reached the maximum size. However, poor mydriasis were found in many eyes despite maximum instillation was used. From the clinical observation, we found the packing of mydriatic drugs in lower conjunctival fornix was much more effective to dilate the pupil than instillation in some patients. The purpose of this study was to compare the mydriatic effect of 2.5% phenylephrine and 1% tropicamide by conventional instillation and lower conjunctival fornix packing in premature infants.

02

Conditions studied

  • Preterm Infants

Browse trials for

Keywords

  • preterm infants
  • mydriasis
  • pupil dilation
03

Who can participate

Ages eligible
1 Month to 4 Months
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • gestational age of less than 32 weeks and/or the birth weight of less than 1,500 grams
  • stable clinical course

Exclusion criteria

Exclusion Criteria:

  • history of intraocular surgery or laser treatment
  • previous eyedrop instillation that might affect the pupil size
  • severe underlying disease or unstable clinical course that mydriatic drugs or the examination could aggravate their conditions
04

Study design

Phase
Phase 4
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    1

    Lower conjunctival fornix packing arm. For the eyes receiving lower conjunctival fornix packing (study group), one small piece of the cotton wool soaked with one drop of 2.5% phenylephrine and one drop of 1% tropicamide was packed in the lower conjunctival fornix.

    Drug: 1% tropicamide and 2.5% phenylephrine

  • Active comparator
    2

    Conventional instillation arm. For the eyes receiving the instillation (control group), 2.5% phenylephrine and 1% tropicamide were alternately instilled every 5 minutes for two doses each.

    Drug: 1% tropicamide and 2.5% phenylephrine

Interventions

  • Drug1% tropicamide and 2.5% phenylephrine

    For the eyes receiving lower conjunctival fornix packing (study group), one small piece of the cotton wool soaked with one drop of 2.5% phenylephrine and one drop of 1% tropicamide was packed in the lower conjunctival fornix. For the eyes receiving the instillation (control group), 2.5% phenylephrine and 1% tropicamide were alternately instilled every 5 minutes for two doses each.

05

What researchers measure

Primary outcomes

  1. The primary outcome measure was the horizontal pupil diameter measured with a ruler in millimeters

    Time frame: 40 minutes after mydriatric drugs

06

Study locations

1 site
  • Srinagarind Hospital
    Khon Kaen, 40002, Thailand
07

References and documents

Publications

  • Thanathanee O, Ratanapakorn T, Morley MG, Yospaiboon Y. Lower conjunctival fornix packing for mydriasis in premature infants: a randomized trial. Clin Ophthalmol. 2012;6:253-6. doi: 10.2147/OPTH.S28714. Epub 2012 Feb 15. PubMed 22368443 ↗
08

Registry details

Key details

Study ID
NCT00877175
Lead sponsor
Khon Kaen University
Responsible party
Yosanan Yospaiboon (Professor, Khon Kaen University) — Principal investigator
First posted
Apr 7, 2009
Start date
Mar 2009
Primary completion
May 2009
Completion
Jun 2009
Last update
Mar 9, 2012

Study contacts

Yosanan Yospaiboon, M.D.
principal investigator · Department of Ophthalmology, Faculty of Medicine, Khon Kaen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion